Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 31, 2019Anticancer ResearchOpen Access

Neoadjuvant Chemotherapy Increases PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

EFEiji FukuokaTokyo-Kita Medical CenterKYKimihiro YamashitaHyogo University of Health SciencesTTTomoko TanakaKobe University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fukuoka et al. (2019) studied this question.

synapsesocial.com/papers/6a0cddfe7aad2cc6fd1f5a37https://doi.org/10.21873/anticanres.13631
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods2018 · 7,851 citations
  2. 2PD-L1 Expression Is a Prognostic Factor in Patients with Thoracic Esophageal Cancer Treated Without Adjuvant Chemotherapy2017 · 42 citations
  3. 3Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8+ T cells2015 · 81 citations
  4. 4Programmed death‐ligand 1 expression at tumor invasive front is associated with epithelial‐mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma2017 · 124 citations